Implantable Cardiac Defibrillators May Fail During High-Voltage Therapy
Certain Medtronic implantable defibrillators may produce reduced or no energy output during high-voltage therapy due to a defective feedthrough component. Affected devices were distributed nationwide and worldwide.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA Class I classification requires a minimum severity rating of 4. Although no illnesses or injuries have been reported and the hazard is described as rare, the potential for reduced or complete failure of high-voltage therapy in implantable cardiac defibrillators—devices critical for preventing sudden cardiac death—justifies this severe rating.
Plain-English summary
The recall affects implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) manufactured with a specific type of glassed feedthrough component. The defect creates a rare potential for reduced or no-energy output during high-voltage therapy, typically at dose levels of 0-12 joules.
The affected devices include the CRTD DTMA2Q1 CLARIA MRI QUAD OUS DF1 model. A total of 1,658 units have been identified as potentially affected. These devices are distributed in the United States and worldwide.
The defective feedthrough component may cause therapy failure when the device needs to deliver high-voltage treatment. Patients with affected devices should contact their healthcare provider or Medtronic immediately. No illnesses or injuries have been reported at this time.
The recalled product
- Product
- CRTD DTMA2Q1 CLARIA MRI QUAD OUS DF1, Model Number DTMA2Q1; Implantable Cardioverter Defibrillators
- Affected units
- 1,658
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- GTIN 00643169837614
- Lot Serial numbers: RPN602297S
- RPN602079S
- RPN601385S
- RPN601320S
- RPN601216S
- RPN601977S
- RPN602107S
- RPN600885S
- RPN601199S
- RPN600682S
- RPN601504S
- RPN601513S
- RPN601653S
- RPN601681S
- RPN602258S
- RPN600961S
- RPN600858S
- RPN600867S
- RPN600868S
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 120 recalled by Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 120 products in this recall →Related recalls
Same manufacturer · Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
See all →- CriticalMedtronic CRT-D Defibrillators: Rare Energy Output Failure Risk During Therapy
FDA (Devices) · 2023-06-28
- SevereMedtronic Implantable Cardioverter Defibrillators Recalled for Reduced Therapy Output
FDA (Devices) · 2023-06-28
- SevereMedtronic Implantable Defibrillators Recalled for Potential Therapy Delivery Failure
FDA (Devices) · 2023-06-28
- SevereImplantable Cardioverter Defibrillators at Risk of Reduced Energy Output
FDA (Devices) · 2023-06-28
- SevereMedtronic Implantable Cardioverter Defibrillator may lose energy output during therapy
FDA (Devices) · 2023-06-28
Same hazard · reduced energy output
See all →- SevereImplantable Defibrillators Risk Therapy Failure Due to Feedthrough Defect
FDA (Devices) · 2023-06-28
- SevereImplantable Defibrillators Recalled for Potential Therapy Delivery Failure
FDA (Devices) · 2023-06-28
- SevereImplantable defibrillators may deliver reduced or no energy during therapy
FDA (Devices) · 2023-06-28
- SevereImplantable cardioverter defibrillators may output reduced or no energy during therapy
FDA (Devices) · 2023-06-28
- SevereImplantable Cardioverter Defibrillators Recalled for Potential Reduced Energy Output
FDA (Devices) · 2023-06-28